Advertisement
Articles
Advertisement

Focus on Outsourcing 6/2/06

Fri, 06/02/2006 - 10:18am
Lentigen Obtains Rights to Lentiviral Technology from UPenn
Lentigen Corp., Baltimore, Md., signed an exclusive, worldwide licensing agreement with the University of Pennsylvania, Philadelphia, to develop and commercialize products from lentiviral vector technology developed at Penn's School of Medicine.
Full Article

Sirna Licenses miRNA Technology from UMass Med School
Sirna Therapeutics Inc., San Francisco, signed a worldwide licensing agreement with the University of Massachusetts Medical School, Worcester, for the rights to patents covering microRNA (miRNA) technology for the modulation of gene expression.
Full Article

HaptoGuard and UTI Sign License for Cardiac Compounds
HaptoGuard Inc., Saddlebrook, N.J., signed a worldwide exclusive license agreement with UTI Limited Partnership, Calgary, Canada, for the rights to a library of compounds developed at the University of Calgary having the potential to treat acute cardiovascular indications.
Full Article

Alnylam Obtains Rights to RNAi Delivery Technology
Alnylam Pharmaceuticals Inc., Cambridge, Mass., obtained the rights to RNAi delivery technology developed at the CBR Institute for Biomedical Research, Boston, that may enable small interfering RNAs to be targeted with an engineered antibody to tumors.
Full Article

Boston Life Sciences Licenses Axon Regeneration Technology
Boston Life Sciences Inc., Hopkinton, Mass., signed exclusive, worldwide license and sponsored research agreements with Children's Hospital Boston for axon regeneration technologies for recovery following severe central nervous system injury currently under development.
Full Article

Harvard Medical to Develop Macular Degeneration Therapy for Merck
Harvard Medical School, Boston, signed a multimillion-dollar license agreement with Merck & Co. Inc., Whitehouse Station, N.J., to develop potential therapies for macular degeneration, and giving Merck licenses to specific molecules to reduce toxicities that develop in the eye.
Full Article


Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading